What is the treatment of choice for bacterial vaginosis?
What is the longest-acting cephalosporin?
What is the recommended treatment regimen for Brucella infection according to WHO guidelines?
All of the following are anti-Pseudomonal drugs except?
What is the mechanism of action of Fluconazole?
What is the treatment for isoniazid-induced neuropathy?
What is the strength of topical ophthalmic preparations of tobramycin?
All penicillins act by:
What is the preferred fluoroquinolone against Mycobacterium leprae?
Which of the following is NOT a third-generation cephalosporin?
Explanation: ### Explanation **Correct Answer: D. Metronidazole** **1. Why Metronidazole is the Correct Choice:** Bacterial Vaginosis (BV) is a clinical syndrome resulting from a shift in the vaginal flora, where normal hydrogen peroxide-producing *Lactobacilli* are replaced by high concentrations of anaerobic bacteria (e.g., *Gardnerella vaginalis*, *Prevotella* spp., and *Mobiluncus* spp.). **Metronidazole** is the drug of choice because it is highly effective against these obligate anaerobes [1]. It works by forming cytotoxic free radicals that disrupt bacterial DNA. According to CDC and WHO guidelines, the standard regimen is **500 mg orally twice daily for 7 days** or 0.75% metronidazole gel intravaginally [2]. **2. Why Other Options are Incorrect:** * **A. Clindamycin:** While Clindamycin is an effective alternative (especially for patients allergic to Metronidazole), it is generally considered a second-line option due to its broader spectrum, which may further disrupt vaginal flora, and its higher cost. * **B. Erythromycin:** This macrolide has poor activity against the specific anaerobic pathogens responsible for BV and is not recommended for treatment. * **C. Ampicillin:** Although *Gardnerella* may show some sensitivity in vitro, Ampicillin is ineffective in vivo for clearing BV and has high failure rates. **3. NEET-PG High-Yield Pearls:** * **Amsel’s Criteria (3 out of 4 required for diagnosis):** 1. Homogeneous, thin, white-grey discharge. 2. Vaginal pH > 4.5. 3. **Positive Whiff Test:** Fishy odor on adding 10% KOH. 4. **Clue Cells** on wet mount (most specific sign). * **Pregnancy:** Metronidazole is safe to use in all trimesters of pregnancy for symptomatic BV [2]. * **Counseling:** Advise patients to avoid alcohol during Metronidazole therapy to prevent a **Disulfiram-like reaction** [2]. * **Partner Treatment:** Unlike Trichomoniasis, routine treatment of the male partner in BV is **not** recommended as it does not prevent recurrence.
Explanation: **Explanation:** **Ceftriaxone** is a third-generation parenteral cephalosporin distinguished by its exceptionally long elimination half-life (approximately **8 hours**). This is significantly longer than most other cephalosporins, which typically have half-lives of 1–2 hours. The prolonged duration of action is due to its high degree of plasma protein binding (approx. 90–95%) and its unique dual route of excretion (40% biliary, 60% renal). This pharmacokinetic profile allows for convenient **once-daily dosing**, making it a preferred choice for outpatient parenteral antibiotic therapy (OPAT). **Analysis of Incorrect Options:** * **Ceftazidime:** A third-generation cephalosporin with a half-life of ~1.5–2 hours. It is primarily used for its potent activity against *Pseudomonas aeruginosa*. * **Cefoperazone:** Another third-generation agent with a half-life of ~2 hours. While it is primarily excreted via bile, it requires twice-daily dosing. * **Cefotaxime:** A third-generation agent with a short half-life (~1 hour) due to rapid metabolism into an active metabolite (desacetylcefotaxime). It usually requires dosing every 6–8 hours. **High-Yield Clinical Pearls for NEET-PG:** * **Biliary Sludging:** Ceftriaxone can precipitate with calcium in the gallbladder, leading to "pseudolithiasis." * **Neonatal Contraindication:** It is avoided in neonates (especially prematures) because it displaces bilirubin from albumin, increasing the risk of **kernicterus**. * **No Renal Adjustment:** Due to its significant biliary excretion, dosage adjustment is generally not required in patients with isolated renal failure. * **DOC:** Ceftriaxone is the drug of choice for **Gonorrhea, Enteric Fever (Typhoid), and Bacterial Meningitis.**
Explanation: **Explanation:** Brucellosis is a zoonotic infection caused by intracellular Gram-negative coccobacilli. Because the bacteria reside within the reticuloendothelial system (macrophages), treatment requires prolonged courses of antibiotics with high intracellular penetration to prevent relapse. **Why Option B is Correct:** According to WHO guidelines, the standard treatment for uncomplicated brucellosis in adults and children over 8 years is the combination of **Doxycycline (100 mg twice daily) and Rifampicin (600–900 mg once daily)** for a duration of **6 weeks**. Doxycycline provides excellent tissue penetration, while Rifampicin adds synergistic intracellular activity, significantly reducing the high relapse rates seen with monotherapy. **Analysis of Incorrect Options:** * **Option A:** While Streptomycin (IM for 2–3 weeks) plus Doxycycline (oral for 6 weeks) is actually considered slightly more effective than the Rifampicin/Doxycycline regimen, it is no longer the first-line WHO recommendation for general cases due to the requirement for daily injections and the risk of ototoxicity/nephrotoxicity. * **Option C:** Ciprofloxacin and other fluoroquinolones are not recommended as first-line agents due to higher rates of treatment failure and relapse compared to tetracyclines. * **Option D:** Erythromycin (a macrolide) has poor clinical efficacy against *Brucella* species and is not part of any standard treatment protocol. **High-Yield Clinical Pearls for NEET-PG:** * **Pregnancy/Children <8 years:** The preferred regimen is **Rifampicin + Trimethoprim-Sulfamethoxazole (TMP-SMX)** for 45 days. * **Neurobrucellosis/Endocarditis:** Requires a triple regimen (Doxycycline + Rifampicin + an Aminoglycoside or Ceftriaxone) for several months. * **Gold Standard Diagnosis:** Bone marrow culture (though Blood culture using BACTEC is more common). * **Serology:** Standard Agglutination Test (SAT) is the most common; a titer >1:160 is significant.
Explanation: **Explanation:** The correct answer is **Cefadroxil**. This question tests the classification and spectrum of activity of Cephalosporins and Penicillins, specifically regarding their efficacy against *Pseudomonas aeruginosa*. **1. Why Cefadroxil is the correct answer:** Cefadroxil is a **First-generation Cephalosporin**. First-generation agents (like Cefazolin and Cephalexin) have a narrow spectrum, primarily targeting Gram-positive cocci and a few Gram-negative organisms (PEcK: *Proteus, E. coli, Klebsiella*). They lack the structural stability to resist the beta-lactamases produced by *Pseudomonas*, making them ineffective against this pathogen. **2. Why the other options are incorrect:** * **Piperacillin (Option A):** An **Antipseudomonal Penicillin** (Ureidopenicillin). It is specifically designed with an extended side chain to penetrate the outer membrane of *Pseudomonas*. It is often combined with Tazobactam. * **Cefoperazone (Option B):** A **Third-generation Cephalosporin** with specific antipseudomonal activity. Notably, it is primarily excreted via bile, making it useful in patients with renal failure. * **Ceftazidime (Option C):** Another **Third-generation Cephalosporin** and historically the "gold standard" for *Pseudomonas* among cephalosporins. **Clinical Pearls for NEET-PG:** * **Antipseudomonal Cephalosporins:** Ceftazidime (3rd gen), Cefoperazone (3rd gen), and Cefepime (4th gen). Note: **Ceftriaxone** (3rd gen) does NOT cover *Pseudomonas*. * **Antipseudomonal Carbapenems:** Imipenem, Meropenem, and Doripenem. **Ertapenem** is the exception (no *Pseudomonas* coverage). * **Other agents:** Aminoglycosides (Amikacin/Tobramycin), Fluoroquinolones (Ciprofloxacin/Levofloxacin), and Monobactams (Aztreonam). * **Mnemonic for 1st Gen Cephalosporins:** "If it has **'pha'** or **'fa'** and ends in **'in'** or **'il'**, it’s 1st gen" (e.g., Ce**pha**lex**in**, Ce**fa**drox**il**).
Explanation: **Mechanism of Action: Fluconazole** **Correct Answer: B. Inhibits lanosterol 14-α-demethylase** Fluconazole is an **Azole** antifungal. Its primary mechanism involves the inhibition of the fungal cytochrome P450 enzyme, **14-α-demethylase**. This enzyme is responsible for converting lanosterol into **ergosterol**, a vital component of the fungal cell membrane. The depletion of ergosterol and the accumulation of methylated sterols lead to increased membrane permeability and fungal cell death. **Explanation of Incorrect Options:** * **A. Inhibits fungal mitosis:** This is the mechanism of **Griseofulvin**, which binds to tubulin and disrupts the mitotic spindle. * **C. Inhibits squalene epoxidase:** This is the mechanism of **Allylamines** (e.g., Terbinafine). It prevents the conversion of squalene to lanosterol, leading to toxic squalene accumulation. * **D. Inhibits β-1,3-glucan synthase:** This is the mechanism of **Echinocandins** (e.g., Caspofungin, Micafungin), which disrupt the synthesis of the fungal cell wall rather than the cell membrane. **High-Yield Clinical Pearls for NEET-PG:** * **Spectrum:** Fluconazole is the drug of choice for *Candida albicans* and Cryptococcal meningitis (maintenance therapy). * **Resistance:** *Candida krusei* is inherently resistant to fluconazole; *Candida glabrata* shows dose-dependent resistance. * **Pharmacokinetics:** It has excellent CSF penetration and is the only azole primarily excreted unchanged in the urine (useful for fungal UTIs). * **Side Effects:** It is a potent inhibitor of CYP enzymes (though less than Ketoconazole), leading to significant drug-drug interactions (e.g., with Warfarin, Phenytoin).
Explanation: **Explanation:** **Mechanism of Action (Why Pyridoxine is correct):** Isoniazid (INH) is a structural analog of **Pyridoxine (Vitamin B6)**. It induces peripheral neuropathy through two primary mechanisms: 1. It inhibits the enzyme **pyridoxine phosphokinase**, which is essential for converting pyridoxine into its active form, pyridoxal-5-phosphate (PLP). 2. It reacts with pyridoxine to form **isonicotinyl-hydrazones**, which are rapidly excreted in the urine. This depletion of Vitamin B6 impairs the synthesis of neurotransmitters like GABA, leading to symmetrical peripheral neuropathy (paresthesia, numbness). Administering supplemental Pyridoxine bypasses this deficiency and prevents/treats the nerve damage. **Analysis of Incorrect Options:** * **A. Thiamine (B1):** Deficiency causes Beriberi and Wernicke-Korsakoff syndrome, typically associated with chronic alcoholism, not INH therapy. * **C. Niacin (B3):** While INH can theoretically cause Pellagra (by inhibiting the conversion of tryptophan to niacin), it is not the primary cause of the characteristic peripheral neuropathy. * **D. Riboflavin (B2):** Deficiency leads to cheilosis, glossitis, and corneal vascularization, but it has no role in INH-induced neurotoxicity. **High-Yield Clinical Pearls for NEET-PG:** * **Prophylactic Dose:** 10–25 mg/day of Pyridoxine is given to high-risk patients (diabetics, alcoholics, pregnant women, malnourished) starting INH. * **Therapeutic Dose:** If neuropathy develops, the dose is increased to 50–100 mg/day. * **Metabolism:** INH is metabolized by **Acetylation** (Phase II reaction). **Slow acetylators** are at a significantly higher risk of developing peripheral neuropathy. * **Sideroblastic Anemia:** INH can also cause microcytic anemia because Vitamin B6 is a cofactor for ALA synthase in heme synthesis.
Explanation: **Explanation:** **Tobramycin** is a potent, broad-spectrum aminoglycoside antibiotic primarily used for treating external ocular infections caused by susceptible bacteria, particularly *Pseudomonas aeruginosa*. **1. Why 3 mg/ml is correct:** The standard concentration for topical ophthalmic tobramycin solution (eye drops) is **0.3%**. In pharmaceutical calculations, a 1% solution equals 10 mg/ml. Therefore, a 0.3% solution corresponds to **3 mg/ml**. This concentration is clinically optimized to provide maximum bactericidal efficacy against common ocular pathogens while remaining non-toxic to the corneal epithelium. **2. Analysis of incorrect options:** * **8 mg/ml (Option B):** This is an arbitrary value and does not correspond to standard ophthalmic formulations. * **10 mg/ml (Option C):** This represents a 1% concentration. While some antibiotics (like Chloramphenicol) are used at 1%, Tobramycin at this strength would increase the risk of local irritation and ocular surface toxicity. * **13 mg/ml (Option D):** This is incorrect. However, it is important to note that "fortified" aminoglycoside drops (used for severe bacterial keratitis) are prepared by pharmacists at much higher concentrations (e.g., 14 mg/ml), but these are not standard commercial preparations. **High-Yield Clinical Pearls for NEET-PG:** * **Spectrum:** Tobramycin has superior activity against *Pseudomonas* compared to Gentamicin. * **Formulations:** It is available as a 0.3% solution (drops) and a 0.3% ointment. * **TobraDex:** A common clinical combination containing Tobramycin (0.3%) and Dexamethasone (0.1%). * **Side Effect:** Prolonged topical use may lead to localized ocular toxicity, including punctate keratitis and lid itching/swelling. * **Mechanism:** Like all aminoglycosides, it inhibits bacterial protein synthesis by binding to the **30S ribosomal subunit**.
Explanation: ### Explanation **Correct Option: B. Inhibiting cell wall synthesis** Penicillins belong to the **Beta-lactam** class of antibiotics. Their primary mechanism of action involves inhibiting the synthesis of the bacterial cell wall. 1. **Binding:** Penicillins bind to specific receptors on the bacterial cytoplasmic membrane called **Penicillin-Binding Proteins (PBPs)** (e.g., transpeptidases). 2. **Inhibition:** They inhibit the **transpeptidation reaction**, which is the final step in peptidoglycan synthesis. This prevents the cross-linking of glycan chains. 3. **Lysis:** The loss of structural integrity, combined with the activation of bacterial autolytic enzymes (murein hydrolases), leads to osmotic rupture and bacterial death (**Bactericidal** action). **Why other options are incorrect:** * **A. Inhibiting protein synthesis:** This is the mechanism for drugs like Aminoglycosides, Tetracyclines, Macrolides, and Chloramphenicol (acting on 30S or 50S ribosomal subunits). * **C. Antifolate:** This describes the mechanism of Sulfonamides (inhibits dihydropteroate synthase) and Trimethoprim (inhibits dihydrofolate reductase). * **D. Inhibits DNA gyrase:** This is the mechanism of **Fluoroquinolones** (e.g., Ciprofloxacin), which inhibit Topoisomerase II (DNA gyrase) and IV. **High-Yield Clinical Pearls for NEET-PG:** * **Resistance:** The most common mechanism of resistance to penicillins is the production of **Beta-lactamases** (penicillinases) that hydrolyze the beta-lactam ring. * **Spectrum:** Natural Penicillin (Pen G) is the drug of choice for **Syphilis** (*Treponema pallidum*). * **Adverse Effect:** The most serious side effect is **Type I Hypersensitivity** (Anaphylaxis). Always perform a Skin Hypersensitivity Test (SHT) before administration. * **Excretion:** Most penicillins are excreted renally via tubular secretion; **Probenecid** can be used to prolong their half-life by inhibiting this secretion.
Explanation: **Explanation:** **Ofloxacin** is considered the preferred fluoroquinolone for the treatment of leprosy. While several fluoroquinolones exhibit bactericidal activity against *Mycobacterium leprae* by inhibiting DNA gyrase, Ofloxacin has been the most extensively studied in clinical trials and is a recognized component of WHO-recommended alternative multidrug therapy (MDT) regimens for patients who cannot tolerate standard drugs like Rifampicin or Dapsone. **Analysis of Options:** * **Ofloxacin (A):** It is highly effective against *M. leprae*. In clinical practice, a dose of 400 mg daily is used. It is the standard fluoroquinolone included in the ROM (Rifampicin, Ofloxacin, Minocycline) regimen for single-lesion paucibacillary leprosy. * **Pefloxacin (B):** While Pefloxacin also shows significant activity against *M. leprae*, it is less commonly used than Ofloxacin due to a higher side-effect profile and less clinical documentation in standard leprosy protocols. * **Ciprofloxacin (C):** Although a potent antibacterial, Ciprofloxacin has relatively low bactericidal activity against *M. leprae* compared to Ofloxacin and is generally not used in leprosy management. * **Moxifloxacin (D):** Moxifloxacin is actually more potent than Ofloxacin *in vitro* and in animal models. However, Ofloxacin remains the "preferred" answer in the context of standard NEET-PG curriculum and established WHO guidelines for alternative MDT. **High-Yield Clinical Pearls for NEET-PG:** * **ROM Regimen:** A single dose of Rifampicin (600 mg), Ofloxacin (400 mg), and Minocycline (100 mg) was previously used for Single Lesion Paucibacillary (SLPB) leprosy. * **Mechanism:** Fluoroquinolones inhibit **DNA Gyrase (Topoisomerase II)**, preventing DNA replication. * **Alternative MDT:** For Rifampicin-resistant leprosy or cases of intolerance, a combination of Ofloxacin, Minocycline, and Clofazimine is often utilized.
Explanation: ### Explanation The classification of cephalosporins into "generations" is a high-yield topic for NEET-PG, primarily based on their chronological development and spectrum of activity. **1. Why Cefuroxime is the Correct Answer:** **Cefuroxime** is a **second-generation cephalosporin** [2]. Unlike third-generation agents, second-generation drugs have intermediate gram-negative activity and enhanced activity against certain gram-positive cocci. Cefuroxime is unique because it is the only second-generation cephalosporin that can cross the blood-brain barrier (though it is no longer the first choice for meningitis). **2. Analysis of Incorrect Options (Third-Generation Agents):** Third-generation cephalosporins are characterized by increased stability against beta-lactamases and superior activity against gram-negative Enterobacteriaceae [3]. * **Ceftriaxone (Option A):** A classic third-generation agent known for its long half-life (once-daily dosing) and biliary excretion. * **Cefotaxime (Option B):** A prototype third-generation agent frequently used for neonatal meningitis due to its excellent CSF penetration [3]. * **Ceftizoxime (Option C):** A third-generation agent with good activity against anaerobes (like *B. fragilis*) [1]. **3. NEET-PG High-Yield Clinical Pearls:** * **Mnemonic for 2nd Gen:** "The **FOX** (**Cefoxitin**) ate a **FUR**ry (**Cefuroxime**) **FAC**on (**Cefaclor**)." * **Mnemonic for 3rd Gen:** Most end in **"-one"**, **"-ime"**, or **"-ten"** (Ceftriax**one**, Cefotax**ime**, Ceftizox**ime**, Ceftazid**ime**, Ceftibu**ten**). *Exception: Cefuroxime ends in "-ime" but is 2nd Gen.* * **Ceftriaxone** is the drug of choice for **Gonorrhea** and **Enteric Fever**. * **Ceftazidime and Cefoperazone** are the only third-generation agents with activity against ***Pseudomonas aeruginosa*** [1]. * **Cefotetan and Cefoperazone** can cause a **Disulfiram-like reaction** with alcohol due to the methylthiotetrazole (MTT) side chain [4].
Beta-Lactam Antibiotics
Practice Questions
Aminoglycosides
Practice Questions
Macrolides and Ketolides
Practice Questions
Tetracyclines
Practice Questions
Quinolones
Practice Questions
Sulfonamides and Trimethoprim
Practice Questions
Antimycobacterial Drugs
Practice Questions
Antifungal Agents
Practice Questions
Antiviral Drugs
Practice Questions
Antiparasitic Agents
Practice Questions
Principles of Antimicrobial Selection
Practice Questions
Antimicrobial Resistance
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free